RecruitingNCT06867172

Prevalence of Pancreatic Steatosis in Pancreatic Cystic Neoplasms and Pancreatic Adenocarcinoma

The Emerging Issue - Pancreatic Steatosis Prevalence in Pancreatic Cystic Neoplasms and Adenocarcinoma: Insights From a Single-center Retrospective Study


Sponsor

Carol Davila University of Medicine and Pharmacy

Enrollment

66 participants

Start Date

Jan 1, 2019

Study Type

OBSERVATIONAL

Conditions

Summary

Several pancreatic neoplastic cystic lesions, such as IPMN (intrapapilary mucinous neoplasia), cystic neuroendocrine tumors (NET) and mucinous neoplasms, present a carcinogenetic risk, though it is yet unknown if this risk is increased in patients with pancreatic steatosis (PS). The primary objective of the study is to determine de prevalence of pancreatic steatosis in pancreatic neoplastic cysts and if pancreatic steatosis is increased in those lesions that pose a carcinogenetic risk. The secondary objective is to evaluate the prevalence of pancreatic steatosis in pancreatic adenocarcinoma.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study looks at whether fatty deposits in the pancreas (pancreatic steatosis) are commonly found in people who have pancreatic cysts or pancreatic cancer, using advanced ultrasound imaging (endoscopic ultrasound, or EUS). **You may be eligible if...** - You are 18 or older - You have at least one pancreatic cyst (5mm or larger) detected on CT or EUS, OR - You have been diagnosed with pancreatic cancer (confirmed by tissue biopsy), OR - You are a healthy volunteer with no known pancreatic disease **You may NOT be eligible if...** - You have a metal stent in your bile duct or pancreatic area - You have a medical condition that makes endoscopy unsafe - You are unwilling to provide written consent Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTcomputerized tomography

Little is known about the prevalence of pancreatic steatosis in patients with pancreatic cystic lesions therefore this observational study aims to clarify the data.

DIAGNOSTIC_TESTEndosonography (EUS)

EUS can better evaluate all pancreatic cysts, therefore is mandatory in this observational study.


Locations(1)

Prof Dr Agrippa Ionescu; Clinical Emergency Hospital

Bucharest, Sector 1, Romania

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06867172


Related Trials